Introduction

inhabitants.
Methods. This report includes data from 21 181 patients from Argentina, Brazil, Chile, El Salvador, The Latin American Society of Nephrology and Panama, Paraguay, Peru, Puerto Rico, Uruguay, and Hypertension (SLANH ) comprises the National Venezuela who were receiving chronic dialysis treat-Societies of Nephrology from 21 countries with a total ment during 1993. Data was collected by individual population of 468.59 million inhabitants. patient questionnaires except from Chile and Brazil
The Latin American Registry of Dialysis and Renal where the data was obtained from a local centre Transplantation was created in October 1991 during questionnaire.
the VIII Congress of the SLANH held in Quito, Results. The prevalence rate averaged 131.1 per million Ecuador. The Registry has a Coordinating Committee population. The mean age of the 8972 incident patients located in Montevideo, Uruguay and National was 50.5 years, with 58.2% males. The more frequent Representatives from each country. The primary causes of renal failure were glomerulopathies (22.6%), objectives, the general organization, and the financing vascular nephropathy (20.9%) and diabetes (16.9%). of the Registry were discussed during the first meeting Haemodialysis was the most used treatment (88.3%). of National Representatives held in Montevideo in Gross mortality was 21.1% and the more frequent May 1994: the main objectives of the Registry are to causes of death were cardiac complications and infec-collect and analyse data of patients on renal replacetions. The analysis of mortality risk factors using a ment therapy (RRT ) from the 21 countries of the logistic regression model showed that diabetics patients region, to contribute to the establishment and developolder than 65 years had the highest probability of ment of national registries, to prepare periodical death (43.0%) and patients with glomerulonephritis, reports about incidence and prevalence of renal disyounger than 65 years had the lowest (8.0%). The eases and the results of RRT, in order to improve the adjusted mortality rate was 241 deaths/1000 patient-outcome. years at risk when the USRDS 1987-1989 white morThis regional registry has very important limitations tality rate by age groups and primary diseases was due to differences in: used as standard.
1. The demography of the population. In countries Conclusion. In spite of the economic difficulties, very like Brazil, there are important race differences and important efforts have been made to treat ESRD the majority of the population is mixed race. The patients and gross mortality statistics in some countries rate of aborigines population is high in Peru. On are similar to those reported by other regional the other hand, in other countries like Uruguay, registries.
there are not substantial race differences and aborigines do not exist. Considerable differences in age 4. The patients accessibility to RRT. In most countries modality. The methodology used has been described in a there are not specific funding strategies and only previous report [5] . patients with social security are accepted for treat- Transplant report was previously published [4] .
SPSS and BMDP software were used to analyse data. Incorrect or incomplete data was eliminated from the data base for quality control.
Methods
Results
The Registry includes all patients alive in any type of dialysis treatment on December 31, 1993 and patients which discon-
The prevalence of estimated patients in RRT, with tinued treatment between January 1, 1993 and December partial data of transplant averaged 131.1 per million 31, 1993. Data was collected from dialysis units and from individual population (pmp) ( Table 1 ). There was a great varipatient questionnaires. The different variables included in ation between countries; the highest prevalence was each questionnaire and the data collection process were found in Puerto Rico (610.1 pmp). Nine countries had described in the first report of the Registry [5] and were >100 patients pmp There was a significant correlation similar to the South American Cone Haemodialysis between estimated prevalence rate and GNP per person Registry [6 ] .
(r=0.63, P=0.0066). The correlation was also signiThe total number of patients in Renal Replacement ficant for estimated prevalence rate and the Human Therapy (RRT ) in each country was estimated by the Development Index (r=0.59, P=0.010).
authorities of the National Societies.
The 10 countries with registered dialysis patients Data from Chile and Brazil were obtained from a local had a population of 271.61 million inhabitants. This centre questionnaire, which included most of the variables considered. Data from Chile was collected during September figure represents 58% of the total population of the 1, 1992 and August 31, 1993, and were considered in phase. countries comprised by SLANH. In these countries, Data from previous reports were used for countries that did the ratio between registered and estimated patients was not send those corresponding data for 1993 [5, 7, 8] . Patient 57.5%. The response was >80% in five countries demographic characteristics were analysed for new patients ( Table 2 ).
starting RRT.
The incidence and prevalence rates of registered Incidence, prevalence, gross mortality and mortality per patients averaged 33.3 and 66.8 pmp, respectively. In 1000 patient-years were defined as in the 1991 USRDS Puerto Rico, Uruguay, and Chile the prevalence of Report [9] . Incidence and prevalence rates were calculated registered patients was >200 pmp ( Table 2) . for registered and total estimated patients. Mortality was Haemodialysis was the most frequent dialysis treatcalculated by age group, primary disease and treatment modality. ment modality in Latin America (88.3%) ( Table 2) . 1993 Latin American Registry of Dialysis 2523 The mean age of the incident patients averaged 50.5 weeks/patient/year, 68.5% of the patients were never hospitalized, and 9.6% had a short time of hospitalizayears. Forty-four per cent of the patients were >55 years and 6.6% >75 years. The mean age ranged from tion (<1 week/year). Only 5.8% of patients were hospitalized for >30 days (Figure 1) . The average 46.6 in Brazil to 57.9 years in Puerto Rico ( Table 3) . Fifty-eight percent of the patients were male.
weeks of hospitalization by age were similar among patients <55 years old. However, the number of The most frequent types of nephropathy were: glomerulonephritis (22.6%), vascular nephropathy (20.9%), hospitalizations increased with age in patients >55 years. Diabetic patients had the highest average and diabetic nephropathy (16.9%). Vascular nephropathy was the most frequent in Uruguay and Venezuela of hospitalization time: 1.96 weeks/patient/year.
Hospitalizations were more frequent in intermittent and diabetes was most frequent in Puerto Rico, Paraguay, Venezuela, Peru, and Argentina ( Table 4) . peritoneal dialysis (IDP) patients (3.12 weeks/patient/ year) than haemodialysis patients (1.24 weeks/patient/ The average number of hospitalizations was 1.1 not include patients from Chile, Brazil, and Puerto Rico because the exact time of exposition to the risk was not known. Mortality rate was greater for haemodialysis than peritoneal dialysis ( Table 5 ).
The most frequent causes of death were: cardiac complications (28.6%) and infections (20.0%) ( Table  6 ). Cardiac and infection mortality rates were 57.5 and 40.2 deaths per 1000 patient-years at risk, respectively.
The evaluation of physical capacity revealed that 43.4% of the patients had no limitations in activity and 6.3% were considered as not able to take care of themselves ( Figure 2 ). During 1993, 3621 patients died and 1012 received renal transplantation.
Patients aged 15-24 years old had the lowest mortality rate (88 per 1000 patient-years); the highest was observed in patients >84 years old (816 per 1000 patient-years). The mortality rate of patients <15 years old (90 per 1000 patient-years) was lower than that observed for 1992 (236 per 1000 patient-years) ( Figure 3 ). There was no difference in mortality rate by sex. Patients with glomerulonephritis had the lowest year) and continuous ambulatory peritoneal dialysis mortality rate (103 per 1000 patient-years) ( Figure 4 ). (CAPD) patients (0.55 weeks/patient/year).
The highest mortality was observed in patients with Gross mortality rate was 21.1% (range: 13.4% in diabetes and myeloma kidney (444 and 497 per 1000 Chile to 29.6% in El Salvador). Mortality rate was patient-years, respectively). 201.1 deaths per 1000 patient-years at risk (range: 152.5 in Peru to 293.7 in El Salvador). This rate did Multivariate analysis showed that age and primary renal disease were significantly associated with mortality. Patients >65 years old and diabetics had the 1987-1989 US mortality rate for Caucasian dialysis patients. SMR ranged from 0.75 for hypertension and highest risk of death (43%). On the other hand, patients <65 years old and glomerulonephritis had the lowest glomerulonephritis to 1.01 for diabetes. The overall SDR was 241 ( Figure 5 ). The rate for each country probability of death (8%).
The SMR was 0.86 indicating that the number of was as follows: Argentina 226; El Salvador 294; Panama 264; Peru 153; Uruguay 156; Venezuela 218. deaths in the registered population was less than the Latin American were lower than rates shown by other registries [9, 19, 20] . During the last years, USA and Japan reported the highest values. In USA the incidence rate was 198 patients pmp in 1991 and in Japan it was 181 pmp in 1992. In Europe, the incidence rate varied greatly in the countries associated with the EDTA. During 1993, the number of incident patients was 55 pmp, with the highest rate in Greece and Sweden (118 and 116 patients pmp, respectively) [18] . The highest prevalence rate were also reported by Japan and USA (996 and 732 patients pmp, respectively). In the EDTA Registry, the prevalence rate averaged 283 pmp in 1992 with three countries (Israel, Spain, and Switzerland ) having >500 patients pmp.
The lower estimated incidence and prevalence rates observed in the SLANH Registry do not represent the actual rates of ESRD patients (treated and nontreated) in Latin America. The main limitation to Fig. 4 . Mortality rate by primary disease. Mortality rate in diabetic ESRD treatments in Latin America is the difficulty to patients was significanthy higher than mortality rate in non diabetic finance high cost treatments. These treatments demand patients (171/1000 patient-years) (P<0.05).
national financing programmes with their own resources.
The highest prevalence were observed in Puerto Rico and Uruguay. Puerto Rico is an Associated State of the USA. so the ESRD patients had the same health care system as this country. In Uruguay, there were only sporadic cases of RRT before 1980. RRT began to spread after the creation of the National Fund of Resources in 1980. This Fund receives contributions from all inhabitants to finance, among other high cost treatments, dialysis and renal transplantation. Thanks to this organization, during the period from 1980-1990 the incidence rate of patients receiving dialysis increased from 8 to 93 patients pmp [21] .
There was a positive correlation between prevalence of patients on RRT and GNP. Some Latin American countries with low GNP showed a prevalence similar to that of developed countries [22] . The mean age of incident patients was 50.5 years without change population reported in the EDTA, but lower than the USRDS population (61 years) [9, 19] .
Discussion
In Latin America, dialysis is the predominated treatment modality. In nine countries with actualized data of prevalence in dialysis and transplant, only 16.8% of In South American countries registration of patients on dialysis has gradually increased in recent years. The RRT patients were living with a functioning kidney transplant ( Table 1 ). The mean number of transplants percentage of registered patients was 26% in 1991 [5] and increased to 47% in 1992 and 57.5% in 1993. In in 1993 was 7.35 pmp with the highest rates in Costa Rica (16.7 pmp) and Cuba (14.3 pmp) (4). 1990 there were 6503 and in 1993 25181 registered patients. Three out of 10 countries registered <40%
As in the EDTA and USRDS registries [9, 18 ] the more frequent nephropathies were glomerulonephritis, of the total estimated patients on renal replacement programs. These percentages are lower than those vascular nephropathy, and diabetes. In the SLANH and EDTA Registries the most frequent primary disobserved in other registries. The percentage of centre response in the EDTA Registry was 79% in 1989 and ease was glomerulonephritis (22.6% and 19.3%, respectively). The frequency of diabetes was similar in 66% in 1993 with 13 countries having a response rate >80% [17, 18] . In USA the registry includes almost all the SLANH and the EDTA Registries but lower than the USRDS. The mean frequency of obstructive patients under treatment [9] .
There was also an increase in the incidence rate from nephropathy in the SLANH Registry was 4.1% and in the USRDS 2.3%. In Uruguay the frequency of 1990 to 1993. The prevalence rate per million population mainly increased in Uruguay and Chile. Incidence obstructive nephropathy was very high (13.1), higher than the SLANH Registry mean. The diagnosis of and prevalence rates of estimated RRT patients in
